73 related articles for article (PubMed ID: 8874516)
21. Structure of the complex of an Fab fragment of a neutralizing antibody with foot-and-mouth disease virus: positioning of a highly mobile antigenic loop.
Hewat EA; Verdaguer N; Fita I; Blakemore W; Brookes S; King A; Newman J; Domingo E; Mateu MG; Stuart DI
EMBO J; 1997 Apr; 16(7):1492-500. PubMed ID: 9130694
[TBL] [Abstract][Full Text] [Related]
22. Generation of a subtype-specific neutralization epitope in foot-and-mouth disease virus of a different subtype.
Hernández J; Martínez MA; Rocha E; Domingo E; Mateu MG
J Gen Virol; 1992 Jan; 73 ( Pt 1)():213-6. PubMed ID: 1370534
[TBL] [Abstract][Full Text] [Related]
23. Serotype-independent detection of foot-and-mouth disease virus.
Muller JD; McEachern JA; Bossart KN; Hansson E; Yu M; Clavijo A; Hammond JM; Wang LF
J Virol Methods; 2008 Jul; 151(1):146-53. PubMed ID: 18440078
[TBL] [Abstract][Full Text] [Related]
24. Gene cloning, bacterial expression, in vitro refolding, and characterization of a single-chain Fv antibody against PreS1(21-47) fragment of HBsAg.
Yang X; Hu W; Li F; Xia H; Zhang Z
Protein Expr Purif; 2005 Jun; 41(2):341-8. PubMed ID: 15866720
[TBL] [Abstract][Full Text] [Related]
25. Cloning, expression, and characterization of single-chain variable fragment antibody against mycotoxin deoxynivalenol in recombinant Escherichia coli.
Choi GH; Lee DH; Min WK; Cho YJ; Kweon DH; Son DH; Park K; Seo JH
Protein Expr Purif; 2004 May; 35(1):84-92. PubMed ID: 15039070
[TBL] [Abstract][Full Text] [Related]
26. Neutralization of foot-and-mouth disease virus. I. Sensitization of the 140S virion by antibody also reactive with the 12S protein subunit.
Hardy MM; Moore DM
J Gen Virol; 1981 Aug; 55(Pt 2):415-27. PubMed ID: 6169797
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of monoclonal antibodies against FMD virus type Asia-1 and determination of antigenic variations in the field strains.
Rana SK; Bagchi T
Vet Immunol Immunopathol; 2008 Apr; 122(3-4):241-9. PubMed ID: 18291535
[TBL] [Abstract][Full Text] [Related]
28. [Gene cloning, expression and immunological identification of a single chain antibody fragment 3D3 against dengue type 3 virus].
Si B; Yang P; Qin E
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Sep; 12(3):229-32. PubMed ID: 12526322
[TBL] [Abstract][Full Text] [Related]
29. [Cloning of variable region genes of anti-tetanus toxoid antibody and their expression as three kinds of engineered antibodies in E. coli].
Zan H; Yeh M
Shi Yan Sheng Wu Xue Bao; 1997 Sep; 30(3):285-92. PubMed ID: 11039023
[TBL] [Abstract][Full Text] [Related]
30. Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site.
Rémond M; Da Costa B; Riffault S; Parida S; Breard E; Lebreton F; Zientara S; Delmas B
Vaccine; 2009 Jan; 27(1):93-8. PubMed ID: 18983883
[TBL] [Abstract][Full Text] [Related]
31. Expression of a foot-and-mouth disease virus immunodominant epitope by a filamentous bacteriophage vector.
Kim YJ; Lebreton F; Kaiser C; Crucière C; Rémond M
Arch Virol; 2004 Feb; 149(2):365-77. PubMed ID: 14745601
[TBL] [Abstract][Full Text] [Related]
32. Escherichia coli expressing single-chain Fv on the cell surface as a potential prophylactic of porcine epidemic diarrhea virus.
Pyo HM; Kim IJ; Kim SH; Kim HS; Cho SD; Cho IS; Hyun BH
Vaccine; 2009 Mar; 27(14):2030-6. PubMed ID: 19428826
[TBL] [Abstract][Full Text] [Related]
33. Cloning and expression of functional single-chain Fv antibodies directed against NIa and coat proteins of potato virus Y.
Rouis S; Lafaye P; Jaoua-Aydi L; Sghaier Z; Ayadi H; Gargouri-Bouzid R
J Virol Methods; 2006 Oct; 137(1):1-6. PubMed ID: 16884787
[TBL] [Abstract][Full Text] [Related]
34. [Cloning of the variable region genes from hybridoma against bFGF and expression of single chain antibody fragments in E.coli HB2151].
Wang H; Chen D; Deng N; Xiang JJ; Jin YJ; Huang HL; Tang Y; Yang HY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Dec; 23(12):1150-3. PubMed ID: 18062890
[TBL] [Abstract][Full Text] [Related]
35. Generation and application of a fluorescein-specific single chain antibody.
Schenk JA; Sellrie F; Böttger V; Menning A; Stöcklein WF; Micheel B
Biochimie; 2007 Nov; 89(11):1304-11. PubMed ID: 17686564
[TBL] [Abstract][Full Text] [Related]
36. Cyclic peptides as conformationally restricted models of viral antigens: application to foot-and-mouth disease virus.
Valero ML; Camarero JA; Adeva A; Verdaguer N; Fita I; Mateu MG; Domingo E; Giralt E; Andreu D
Biomed Pept Proteins Nucleic Acids; 1995; 1(3):133-40. PubMed ID: 9346844
[TBL] [Abstract][Full Text] [Related]
37. Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.
Juárez-González VR; Riaño-Umbarila L; Quintero-Hernández V; Olamendi-Portugal T; Ortiz-León M; Ortíz E; Possani LD; Becerril B
J Mol Biol; 2005 Mar; 346(5):1287-97. PubMed ID: 15713481
[TBL] [Abstract][Full Text] [Related]
38. A note on outbreaks caused by mixed foot-and-mouth disease virus infections.
Gajendragad MR; Prabhudas K; Gopalakrishna S; Suryanarayana VV; Natarajan C
Acta Virol; 1999 Feb; 43(1):49-52. PubMed ID: 10672344
[TBL] [Abstract][Full Text] [Related]
39. [Relationship between the chemical structure and the biological activity of antibodies against the foot-and-mouth disease virus].
Veleva EB
Vet Med Nauki; 1977; 14(2):89-94. PubMed ID: 199988
[TBL] [Abstract][Full Text] [Related]
40. Induced pocket to accommodate the cell attachment Arg-Gly-Asp motif in a neutralizing antibody against foot-and-mouth-disease virus.
Verdaguer N; Mateu MG; Bravo J; Domingo E; Fita I
J Mol Biol; 1996 Feb; 256(2):364-76. PubMed ID: 8594203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
